CODX Co-Diagnostics

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: on the page, or accessible directly

Conference Call: 800-715-9871 (Toll Free) or (646) 307-1963 (Toll) with participant passcode 1977478

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to identify genetic markers for use in applications other than infectious disease.

Investor Relations Contact:

Andrew Benson

Head of Investor Relations





EN
29/04/2025

Underlying

CODXCo-Diagnostics

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Co-Diagnostics

 PRESS RELEASE
Free
CODX CO-DIAGNOSTICS

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Results:  ●Revenue of $0.1 million, which declined from $0.5 million during the Q1 2024 primarily due to timing of grant revenue recognition. The Company did not recognize any grant revenue during the first quarter 2025    ●O...

20h / 22m 1 EN
 PRESS RELEASE
Free
CODX CO-DIAGNOSTICS

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Dat...

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan...

April 29, 2025 1 EN
Free Trial
CODX CO-DIAGNOSTICS

Co-Diagnostics Inc: 1 director

A director at Co-Diagnostics Inc sold 2,000 shares at 10.455USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

09/22/21 September 22, 2021 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 222.65
DXCM DEXCOM INC.
AMGN AMGEN INC. ... (+91)

Vermilion Compass: Weekly Equity Strategy

The Only Thing We Have To Fear Is Fear Itself This powerful quote from FDR can be applied to many facets of life. When it comes to the market, fear can lead investors to buy when it is time to sell, sell when it is time to buy, or freeze up altogether. Step one in conquering this issue starts with preparation and a gameplan. In our report from last Thursday (3/12) titled “Searching For A Bottom” we laid out our gameplan and what we need to see before having confidence that equity markets ar...

DXCM DEXCOM INC.
AMGN AMGEN INC.
TSFA TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD. SPONSORED ADR
DPZ DOMINO'S PIZZA INC.
LITE LUMENTUM HOLDINGS INC.
ITW ILLINOIS TOOL WORKS INC.
AMN AMN HEALTHCARE SERVICES INC.
NOW SERVICENOW INC.
MASI MASIMO CORPORATION
AAON AAON INC.
XLRN ACCELERON PHARMA INC
WST WEST PHARMACEUTICAL SERVICES INC.
WEC WEC ENERGY GROUP INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
VNET 21VIANET GROUP INC. SPONSORED ADR CLASS A
VIPS VIPSHOP HOLDINGS LTD SPONSORED ADR
TSLA TESLA INC
TMO THERMO FISHER SCIENTIFIC INC.
TDOC TELADOC HEALTH INC.
STMP STAMPS.COM INC.
SGEN SEAGEN INC.
SEDG SOLAREDGE TECHNOLOGIES INC.
RMD RESMED INC.
RGEN REPLIGEN CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
QDEL QUIDEL CORPORATION
POWI POWER INTEGRATIONS INC.
PG PROCTER & GAMBLE COMPANY
NOVA NOVO NORDISK A/S ADS
NVDA NVIDIA CORPORATION
NEH NETEASE INC. SPONSORED ADR
MUSA MURPHY USA INC.
MNST MONSTER BEVERAGE CORPORATION
3KA STRIDE INC.
LMNX LUMINEX CORP
LLY ELI LILLY AND COMPANY
KR KROGER CO.
KMB KIMBERLY-CLARK CORPORATION
K KELLOGG COMPANY
JNJ JOHNSON & JOHNSON
JD JD.COM INC. SPONSORED ADR CLASS A
INO INOVIO PHARMACEUTICALS INC.
HRL HORMEL FOODS CORPORATION
HAIN HAIN CELESTIAL GROUP INC.
GIS GENERAL MILLS INC.
FLO FLOWERS FOODS INC.
EPZM EPIZYME INC.
N1U NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC. SPONSORED ADR
EBS EMERGENT BIOSOLUTIONS INC.
DVA DAVITA INC.
DQ DAQO NEW ENERGY CORP SPONSORED ADR
CLX CLOROX COMPANY
CASY CASEY'S GENERAL STORES INC.
CALM CAL-MAINE FOODS INC.
BIIB BIOGEN INC.
A117ME ALIBABA GROUP HOLDING LTD. SPONSORED ADR
ALLT ALLOT LTD
AKAM AKAMAI TECHNOLOGIES INC.
ABC AMERISOURCEBERGEN CORPORATION
SCI SERVICE CORPORATION INTERNATIONAL
APS. APTOSE BIOSCIENCES
BIO BIO-RAD LABORATORIES INC. CLASS A
CCI CROWN CASTLE INTERNATIONAL CORP
ENPH ENPHASE ENERGY INC.
ZNGA ZYNGA INC. CLASS A
TR TOOTSIE ROLL INDUSTRIES INC.
EVBG EVERBRIDGE INC.
WDFC WD-40 COMPANY
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
WMT WALMART INC.
ASML ASML HOLDING N.V.
CODX CO-DIAGNOSTICS
KALA KALA PHARMACEUTICALS INC.
BKI BLACK KNIGHT INC.
ZLAB ZAI LAB LTD. SPONSORED ADR
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
CTXS CITRIX SYSTEMS INC.
RHHBY ROCHE HOLDING AG ADS
RCUS ARCUS BIOSCIENCES
BILI BILIBILI INC. SPONSORED ADR CLASS Z
DOCU DOCUSIGN INC.
ZM ZOOM VIDEO COMMUNICATIONS INC. CLASS A
RAD RITE AID CORPORATION
VAPO VAPOTHERM
CLVT CLARIVATE PLC (A)
BJ BJ'S WHOLESALE CLUB HOLDINGS
VIR VIR BIOTECHNOLOGY
GSX GSX TECHEDU INC. SPONSORED ADR CLASS A
03/17/20 March 17, 2020 62 EN
 PRESS RELEASE
Free
CODX CO-DIAGNOSTICS

Co-Diagnostics and CoSara to Launch IVD Products to India Market

Co-Diagnostics and CoSara to Launch IVD Products to India Market CoSara tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus recently granted regulatory approval by CDSCO to formally launch at India Diagnostic Expo Salt Lake City, Jan. 01, 2020 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the upcoming India Diagnostic Expo with its Indian joint venture, CoSara Diag...

January 2, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch